Abiopharma

News list

📋 LOSCALZO JOSEPH (Director) plans to sell 54K shares of IONIS PHARMACEUTICALS INC (at $80.00 each, total $4.3M) Filed: May 04, 2026 | ID: 000144

Full text

News bot May 4, 2026, 10:06 p.m.
📋 Form 144 Filing: LOSCALZO JOSEPH

Company: IONIS PHARMACEUTICALS INC

Filing Date: 2026-05-04

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 54,321
- Price per Share: $80.00
- Total Value: $4,345,680.00
- Planned Sale Date: 2026-05-04
- Broker: Stifel Nicolaus & Company Inc
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 000-19125
- Issuer Contact Phone: 7609319200
- Issuer Address: 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Broker Address: 501 N Broadway, St. Louis, MO, 63102
- Shares Outstanding: 165262556.0
- Number of Securities to be Sold: 5
- Number of Past Sales: 2
- Signature: /s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Joseph Loscalzo